NCT05868057

A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets

Clinical Studies Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets (Single-center, Randomized, Open-label, Crossover)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To assess the relative bioavailability of SHR7280 dry suspension and tablets in healthy subjects. To assess the safety and tolerability of a single dose of SHR7280 dry suspension and tablets.

Conditions

• Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction

Interventions

Type	Name	Description
DRUG	SHR7280 tablets	SHR7280 tablets 1 time
DRUG	SHR7280 dry suspension	SHR7280 dry suspension 1 time

Timeline

• Start date: 2023-05-23
• Primary completion: 2023-06-09
• Completion: 2023-10-20
• First posted: 2023-05-22
• Last updated: 2023-12-08

Locations

1 site across 1 country: China